(EMAILWIRE.COM, December 16, 2022 )
The global nucleic acid isolation and purification market is projected to reach USD 9.2 billion by 2027 from USD 6.3 billion in 2022, at a CAGR of 7.9% during the forecast period.
Major Growth Driving Factors:
The growth of this market can mainly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies and improving regulatory & reimbursement scenario are expected to offer a wide range of growth opportunities for players in the market.
Due to the rapid spread of the coronavirus, the demand for diagnostic kits and other critical care medical devices has witnessed exponential growth in the last two years. In 20202021, healthcare provider facilities across the globe were overwhelmed with patient submissions for COVID-19 screening & treatment. This resulted in severe disruptions in clinical workflows within inpatient care facilities, leading to the prioritization of critical patient care procedures by provider facilities.
Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287
By product, the kits segment accounted for the largest market share in 2021.
On the basis of product, the nucleic acid isolation and purification market has been segmented into kits, reagents, and instruments. The kits segment accounted for the largest share of the global nucleic acid isolation and purification market in 2021. Growth in this market can be attributed to the increasing demand for kits and reagents for DNA and RNA isolation during research studies carried out to understand genetic abnormalities.
By application, the diagnostics segment is expected to grow at the highest CAGR during the forecast period.
On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications. The diagnostics segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment can be attributed to the growing awareness of genomic diagnostics among patients and the increasing efficiency of genomics sequencing in the diagnosis of diseases. Also, the increasing use of DNA and RNA isolation for screening and detecting pathogens and microorganism in routine samples and rapid adoption of PCR techniques to detect genetic abnormalities is expected to drive the segment growth.
By Type, the plasmid DNA isolation and purification segment accounted for the largest market share in 2021.
On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. In 2021, the plasmid DNA isolation segment accounted for the largest share of the market. The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection. Moreover, the availability of a broad range of kits for extraction and processing of plasmid DNA, and the increasing application in gene expression profiling is further contributing to segment growth.
North America dominates the nucleic acid isolation and purification market during the forecast period.
In 2021, North America accounted for the largest share of the nucleic acid isolation and purification market, followed by Europe. The large share of this region can be attributed to factors such as significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region. With rapid development in molecular biotechnology, novel detection techniques and molecular diagnostic represented by nucleic acid hybridization and nucleic acid sequence analysis are becoming increasingly significant in various medical fields. Hence, leading players in the market are focusing on entering into a strategic collaboration to develop novel products. For instance, in Market 2020, Zymo Research announced entering into collaboration with, a laboratory instruments and solutions provider, Tecan to launch ready-to-use processing products for streamlining DNA and RNA extraction for nucleic acid hybridization. Such product launches are expected to facilitate the growth in the North American region. However, the Asia Pacific region is expected to grow at the highest rate during the forecast period.
Request Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=229978287
The prominent players in this market are QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Merck KGaA (Germany), Bio-Rad Laboratories (US), Agilent Technologies (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), and Omega Bio-tek (US).
Read More About Related Topics:
Genomics Market – Global Future Forecasts to 2025
Metagenomic Sequencing Market – Global Future Forecasts to 2027
Label-free Detection Market – Global Future Forecasts to 2025
Isothermal Nucleic Acid Amplification Technologies- Market – Global Future Forecasts to 2024
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the “Growth Engagement Model GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarketss flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.